He was admitted to the Middlesex Hospital in August 1990 with a four day history of generalised headache and nausea. On examination there was slight ataxia but no other neurological signs were evident. Urea and electrolyte levels and liver function tests were normal, CT of the head showed atrophy only; in particular there was no hydrocephalus and no cryptococcomas were seen. The CD4 count was 40/mm3. Blood cultures were negative for fungi, acid and alcohol fast bacilli (AAFB) and bacteria. At lumbar puncture there were 20 lymphocytes/mm3, CSF/plasma glucose ratio was 17/5.1 mmol/l and CSF protein was 0.69 g/l. Gram, auramine and India ink stains of CSF were negative and culture for bacteria and mycobacteria, viruses and fungi were all negative. Syphilis and toxoplasmosis serology were negative in CSF and blood. The CRAG titre in CSF was 1 in 256 and in blood was 1 in 2052. The Hickman line entry site was painful and red and there was crusting sero-purulent discharge from this site. Culture from the skin site (and from the catheter tip) grew Staphlococcus aureus (sensitive to flucloxacillin). The patient was treated with intravenous flucloxacillin and the Hickman line was removed.
. Investigations showed normal urea and electrolyte levels and liver function tests; CT of the head was normal. Blood and urine culture was negative, India ink staining of CSF was positive for Cryptococcus neoformans and this organism was cultured from CSF. The CSF protein was 0.42 g/l, 30 lymphocytes/mm3 were seen and the CSF/plasma glucose ratio was 2.2/5.6 mmol/l. Cryptococcal antigen (CRAG) titre, using latex agglutination, was 1 in 2052 in both CSF and in blood.
The patient was treated with intravenous amphotericin B, 1 mg/kg/day for four weeks and responded well clinically; at repeat lumbar puncture performed after four weeks treatment the CSF CRAG had fallen to 1 in 256. Subsequently the patient was maintained on oral fluconazole 400 mg daily. This was discontinued in October 1989 because of abnormal liver function tests. The patient rapidly developed headache and was admitted in November of that year. Investigations then showed normal urea and electrolyte levels and liver function tests and negative blood cultures. Blood CRAG was 1 in 5000, CSF CRAG was 1 in 1026. Cultures of CSF were positive for C neoformans. The patient was given a further course of intravenous amphotericin B for four weeks and subsequently a Hickman line was inserted; he then received 0.5 mg/kg of amphotericin intravenously once weekly, as maintenance therapy and began Fansidar two tablets once weekly for primary prophylaxis against pneumocystis pneumonia.
He remained well until April 1990 when he had a further relapse of meningitis whilst receiving maintenance, which was again treated with four weeks of amphotericin B at a dose of 1 mg/kg/day. He then went back onto weekly maintenance amphotericin at the doses given above.
He was admitted to the Middlesex Hospital in August 1990 with a four day history of generalised headache and nausea. On examination there was slight ataxia but no other neurological signs were evident. Urea and electrolyte levels and liver function tests were normal, CT of the head showed atrophy only; in particular there was no hydrocephalus and no cryptococcomas were seen. The CD4 count was 40/mm3. Blood cultures were negative for fungi, acid and alcohol fast bacilli (AAFB) and bacteria. At lumbar puncture there were 20 lymphocytes/mm3, CSF/plasma glucose ratio was 17/5.1 mmol/l and CSF protein was 0.69 g/l. Gram, auramine and India ink stains of CSF were negative and culture for bacteria and mycobacteria, viruses and fungi were all negative. Syphilis and toxoplasmosis serology were negative in CSF and blood. The Histopathology revealed a haemorrhagic pneumonia due to vascular damage from invasion of pulmonary arterial walls by Gram negative bacilli. Mycobacteriosis was seen in some small bowel villi and in the intraabdominal nodes. The portal tracts of the liver were inflamed but there were no features of drug-induced hepatitis. The adrenals had minor cytomegalovirus infection. Cryptococcal infection was seen diffusely in the cerebral and spinal meninges; unlike the appearances in untreated cases, most of the yeasts were within macrophages rather than fluconazole was used). Despite this there was a steady deterioration in the patient's condition, with a further rise in serum creatinine and he became anuric. Terminally he became increasingly confused and hypotensive, ultimately developing cardiogenic shock from which he died.
Pathology (Dr S B Lucas) Externally the patient was wasted. Both heart and lungs (weights 430 g and 410 g) appeared normal. The liver was of normal size (1800 g) and appearance, but the spleen was enlarged (510 g) and showed white pulp atrophy. The mesenteric and para-aortic lymph nodes were 5 mm in diameter, white and firm. The left lobe of the thyroid contained a fleshy encapsulated tumour. The brain (weight 1410 g) and meninges were externally normal, but on slicing, the lateral ventricles were compressed to slits. The basal ganglia contained microcysts (fig 4) which extended down into the thalamus and substantia nigra. Externally the spinal cord was normal.
Histopathologically, florid cryptococcosis, with much budding of yeasts, was present in lymph nodes, meninges, brain parenchyma, liver, spleen, kidney and adrenals. In the lymph nodes it replaced the lymphoid tissue and in the kidneys, yeasts were present in most glomeruli ( fig 5) and in the interstitium. Less severe cryptococcal infiltration had occurred in lungs, heart, thyroid, pancreas, bone marrow and anus. The cerebrum also had multi nucleate giant cell encephalitis. The thyroid tumour was a benign follicular odenoma.
Conclusions of necropsy
Major cause of death was (1) Disseminated cryptococcosis. Minor pathologies were (1) giant cell encephalitis, (2) Most data are derived from the HIV positive patient population and fluconazole is less often used as first line treatment in non-HIV infected patients. Data also suggest that following a primary "induction" course of treatment, the chances of achieving a cure are very low in HIV infected patients with cryptococcal meningitis, probably 30% or less, which is in marked contrast to other immunosuppressed patients. So the strategy employed most widely involves an induction course of treatment followed by long-term maintenance therapy.
In the first case fluconazole was stopped because of abnormal liver function tests. Fluconazole has a good safety record. As it is an azole it is a possible cause of hepatotoxicity, but this is a rare occurrence. It is unclear in this case whether the fluconazole was relevant to liver dysfunction but stopping the fluconazole was a reasonable decision. The other interesting aspect of this case was the initial treatment. Induction therapy used iv amphotericin B for 4 weeks (an appropriate choice). There is considerable debate as to whether flucytosine should be added to amphotericin B in the initial phases of treatment in HIV infected patients. This debate has not been resolved.14 In contrast, in non-HIV infected individuals use of flucytosine in addition to amphotericin B has been demonstrated to be superior to amphotericin B alone. 
